Refractory Cytopenia with Multilineage Dysplasia and Ring Sideroblasts

Known as: RCMD-RS, Refractory Cytopenia with Multilineage Dysplasia and Ringed Sideroblasts 
A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia, dysplastic changes in 10% or more of the cells in two or more of the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
012320052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Refractory anemia with ring sideroblasts (RARS) is a myelodysplastic syndrome (MDS) characterized by isolated erythroid dysplasia… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2013
Review
2013
Refractory anemia with ring sideroblasts (RARS) is a subtype of myelodysplastic syndrome (MDS) characterized by 15% or more ring… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
SF3B1 mutations were recently reported in myelodysplastic syndromes (MDSs), especially in the presence of ring sideroblasts (RSs… (More)
  • table 1
  • figure 1
Is this relevant?
2012
2012
Recent studies report SF3B1 mutations in about 20% of persons of European descent with myelodysplastic syndromes (MDS). Mutations… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2010
2010
ESAs are increasingly used to treat anemia of lower risk MDS, even before RBC transfusion requirement. From a previously… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
2009
2009
PURPOSE Cryptic chromosomal aberrations, such as regions of uniparental disomy (UPD), have been shown to harbor homozygous… (More)
Is this relevant?
2009
2009
Allogeneic stem cell transplantation is the only known curative therapy for myelodysplastic syndromes (MDS). We present the… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Low-risk myelodysplastic syndrome (MDS) with normal cytogenetics accounts for approximately 50% of MDS patients. There are no… (More)
Is this relevant?
2006
2006
The main objective of this study was to evaluate the role of the recent World Health Organization (WHO) classification for… (More)
Is this relevant?